Follow
Christopher J. M. Scott
Christopher J. M. Scott
Sunnybrook Research Institute
Verified email at sri.utoronto.ca
Title
Cited by
Year
White matter hyperintensities and Alzheimer's disease susceptibility: a genome-wide interaction study
YY Wong, CY Wu, DK Mori-Fegan, S Noor, LY Xiong, SS Mirza, ...
Alzheimer's Association International Conference, 2024
2024
Brain functional connectivity and neuropsychiatric symptoms in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease
N Rashidi-Ranjbar, NW Churchill, SE Black, S Kumar, MC Tartaglia, ...
Alzheimer's Association International Conference, 2024
2024
Sex-specific relationships among risk factors in those with Mild Cognitive Impairment or Alzheimer’s disease and healthy controls
B Intzandt, J Ramirez, B Lam, M Masellis, CJM Scott, G Einstein, L Bherer, ...
Alzheimer's Association International Conference, 2024
2024
Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseases
D Andriuta, J Ottoy, M Ruthirakuhan, G Feliciano, AA Dilliott, RA Hegele, ...
Alzheimer's & Dementia, 2024
2024
SegcsvdWMH: A convolutional neural network-based tool for quantifying white matter hyperintensities in heterogeneous patient cohorts
E Gibson, J Ramirez, LA Woods, J Ottoy, S Berberian, CJM Scott, V Yhap, ...
medRxiv, 2024.06. 20.24309230, 2024
2024
History of traumatic brain injury is associated with increased grey-matter loss in patients with mild cognitive impairment
MA Khoury, NW Churchill, A Di Battista, SJ Graham, S Symons, AK Troyer, ...
Journal of Neurology, 1-11, 2024
2024
Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology
K Xhima, J Ottoy, E Gibson, K Zukotynski, C Scott, GJ Feliciano, S Adamo, ...
Alzheimer's & Dementia 20 (5), 3687-3695, 2024
2024
Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study
R Sakurai, F Pieruccini‐Faria, B Cornish, J Fraser, MA Binns, D Beaton, ...
Alzheimer's & Dementia 20 (4), 2968-2979, 2024
12024
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal study
N Rashidi‐Ranjbar, NW Churchill, SE Black, S Kumar, MC Tartaglia, ...
International Journal of Geriatric Psychiatry 39 (3), e6074, 2024
2024
Neural Correlates of Mild Behavioral Impairment in older adults across the neurodegenerative spectrum
N Rashidi‐Ranjbar, NW Churchill, SE Black, S Kumar, C Tartaglia, ...
Alzheimer's & Dementia 19, e073460, 2023
2023
Rare neurovascular genetic and imaging markers across neurodegenerative diseases
AA Dilliott, SA Berberian, KM Sunderland, MA Binns, J Zimmer, ...
Alzheimer's & Dementia 19 (12), 5583-5595, 2023
2023
Perivascular spaces mediate a relationship between diabetes and other cerebral small vessel disease markers in cerebrovascular and neurodegenerative diseases
J Zebarth, R Kamal, G Perlman, M Ouk, LY Xiong, D Yu, WZ Lin, ...
Journal of Stroke and Cerebrovascular Diseases 32 (9), 107273, 2023
42023
Association of dual-task gait cost and white matter hyperintensity burden poststroke: results from the ONDRI
F Pieruccini-Faria, B Cornish, M Binns, J Fraser, SMH Haddad, ...
Neurorehabilitation and Neural Repair 37 (7), 434-443, 2023
42023
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases
M Ozzoude, B Varriano, D Beaton, J Ramirez, S Adamo, MF Holmes, ...
Alzheimer's research & therapy 15 (1), 114, 2023
42023
Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease
J Ottoy, M Ozzoude, K Zukotynski, MS Kang, S Adamo, C Scott, J Ramirez, ...
Journal of Cerebral Blood Flow & Metabolism 43 (6), 921-936, 2023
52023
Relationships between polymorphisms in EPHX2, CYP2J2, CYP2C9, and CYP2C8, white matter hyperintensities, and regional atrophy
YY Wong, D Yu, LY Xiong, SS Mirza, E Rogaeva, MJ Chenoweth, ...
Alzheimer's & Dementia 19, e061618, 2023
2023
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative
DC Carvalho de Abreu, F Pieruccini‐Faria, Y Sarquis‐Adamson, A Black, ...
European Journal of Neurology 30 (4), 920-933, 2023
82023
Vascular burden and cognition: mediating roles of neurodegeneration and amyloid PET
J Ottoy, M Ozzoude, K Zukotynski, S Adamo, C Scott, V Gaudet, J Ramirez, ...
Alzheimer's & Dementia 19 (4), 1503-1517, 2023
222023
Secondary thalamic atrophy related to brain infarction may contribute to post-stroke cognitive impairment
J Geng, F Gao, J Ramirez, K Honjo, MF Holmes, S Adamo, M Ozzoude, ...
Journal of Stroke and Cerebrovascular Diseases 32 (2), 106895, 2023
32023
Soluble epoxide hydrolase derived linoleic acid oxylipins, small vessel disease markers, and neurodegeneration in stroke
D Yu, N Liang, J Zebarth, Q Shen, M Ozzoude, M Goubran, JS Rabin, ...
Journal of the American Heart Association 12 (1), e026901, 2023
82023
The system can't perform the operation now. Try again later.
Articles 1–20